Minivelle FDA Approval History
FDA Approved: Yes (First approved October 29, 2012)
Brand name: Minivelle
Generic name: estradiol
Dosage form: Transdermal System
Company: Noven Pharmaceuticals, Inc.
Treatment for: Prevention of Osteoporosis, Postmenopausal Symptoms
Minivelle (estradiol) is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause, and for the prevention of postmenopausal osteoporosis.
Development timeline for Minivelle
| Date | Article |
|---|---|
| Sep 24, 2014 | Approval Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
